STVN Stock Analysis: Buy, Sell, or Hold?
STVN - Stevanato Group S.p.A.
$21.03
-1.27 (-5.70%)
▼
5d:
-6.95%
30d:
+4.11%
90d:
+12.7%
WAIT
LOW Confidence
Analysis Updated: Aug 28, 2026 12:00 AM ET
Earnings: Aug 04, 2026
0d
Get Alerted When STVN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: STVN shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: STVN shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$32.47
Based on 11.7% avg growth
INTRINSIC VALUE TODAY
$20.16
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: STVN is currently trading at $21.03, which is considered extended relative to its 30-day fair value range of $19.53 to $21.48. From a valuation perspective, the stock is trading at a premium (Forward PE: 26.5) compared to its historical average (22.4). At these levels, the market is pricing in 5.9% annual earnings growth.
Technical Outlook: Technically, STVN is in a strong uptrend. The price is currently testing key support at $20.86. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.7% recently.
Market Sentiment: STVN scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $24.83 (+11.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, STVN is in a strong uptrend. The price is currently testing key support at $20.86. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.7% recently.
Market Sentiment: STVN scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $24.83 (+11.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$19.53 -
$21.48
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
24.8%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (36/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.7%)
- BULLISH: Trading below Wall St target ($24.83)
- BULLISH: Expecting earnings turnaround to 5.9% growth with 7.8% revenue growth
- WARNING: Composite score 47/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$19.53 -
$21.48
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$20.86
Resistance Level
$23.18
Current Trend
Strong Uptrend
Technical data as of
Aug 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
26.54
Wall Street Target
$24.83
(+11.3%)
Revenue Growth (YoY)
7.8%
Earnings Growth (YoY)
-26.5%
Profit Margin
11.0%
Valuation Premium vs History
+5.9% premium
PE vs Historical
26.5 vs 22.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.9%
(market-implied from PE analysis)
1-Year Target
$23.62
(+6%)
2-Year Target
$25.01
(+12%)
3-Year Target
$26.48
(+19%)
3-Yr Target (if PE normalizes)
(PE: 27→22)
PE COMPRESSION
$22.35
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 26.5, Growth: 19.3%)
$37.87
(+70%)
Base:
(SPY PE: 20.1, Growth: 19.3%)
$28.64
(+28%)
Bear:
(PE: 17.1, Growth: 19.3%)
$24.35
(+9%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (40x PE), but valuation improves significantly next year (27x PE) as earnings recover.
Trailing PE: 39.96 | Current EPS (TTM): $0.56
Bull Case
$36.94
(+76%)
Analyst growth 50.1%, PE expands to 44.0
Base Case
$33.58
(+60%)
Market implied 50.1%, PE stable at 40.0
Bear Case
$15.22
(-28%)
Severe decline -20.0%, PE contracts to 34.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 29, 2026 7:44 AM ET
Data refreshes hourly during market hours. Next update: 8:44 AM
Data refreshes hourly during market hours. Next update: 8:44 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STVN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$478 | 43 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$85 | 39 SELL |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 36 SELL |
|
ALGN
Align Technology Inc |
BUY
18 analysts |
$209 | 50 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$246 | 38 SELL |
